Checkpoint Therapeutics, Inc.
CKPTDelisted May 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651407
Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Checkpoint Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 62 | 1 | 57 | −4 |
| Shares | 10.0M | 1.61K | 11.4M | +1.41M (+14.1%) |
| Value | $10.3M | $1.66K | $11.7M | +$1.43M (+13.9%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Spotlight Asset Group, Inc. | 661,597 | $622.0K | 0.62% |
| PVG Asset Management Corp | 392,375 | $408.1K | 1.58% |
| Atom Investors LP | 68,734 | $71.0K | 0.02% |
| First Manhattan Co | 1,000 | $1.00K | 0.00% |
| Baader Bank INC | 88,200 | – | – |
Sold out (9)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Simplex Trading, LLC | 50,637 | $52.0K |
| Virtu Financial LLC | 49,784 | $51.0K |
| HRT Financial LP | 11,396 | $11.0K |
| Northwestern Mutual Wealth Management Co | 7,500 | $8.00K |
| Spire Wealth Management | 5,000 | $5.00K |
| Total Clarity Wealth Management, Inc. | 3,000 | $3.00K |
| Captrust Financial Advisors | 750 | $1.00K |
| FMR LLC | 100 | $0 |
| Cook Wealth Management Group LLC | 15,558 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 1,611 | $1.66K |